(Q48052209)
Statements
1 reference
A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma. (English)
1 reference
Manfred Westphal
Oliver Heese
Joachim P Steinbach
Oliver Schnell
Gabriele Schackert
Maximilian Mehdorn
Dirk Schulz
Matthias Simon
Uwe Schlegel
Karsten Geletneky
Christian Braun
Joachim G Hartung
Dirk Reuter
Monika Warmuth Metz
Ferdinand Bach
20 January 2015
1 reference